Showing results (821-830 of 989) with videos related to

Sort By:
Pageof 99
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 8, 2022
Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind StudyRubi K Li, Eriko Tokunaga, Hryhoriy Adamchuk, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Pythia: Non-random DNA repair allows predictable CRISPR/Cas9 integration and gene editingThomas Naert, Taiyo Yamamoto, Shuting Han, et al.
Medicine and Pharmacy Reports|August 14, 2023
Epigenetic methylation changes: implication as biomarkers in oral and maxillofacial area cancersOvidiu Aghiorghiesei, Alexandra Iulia Irimie, Cornelia Braicu, et al.
Bioinformatics (Oxford, England)|October 3, 2015
JEPEGMIX: gene-level joint analysis of functional SNPs in cosmopolitan cohortsDonghyung Lee, Vernell S Williamson, T Bernard Bigdeli, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 2, 2022
Alterations of cholesterol synthesis and absorption in obstructive sleep apnea: Influence of obesity and disease severityAleksandra Zeljković, Ana Milojević, Sandra Vladimirov, et al.
Biomolecules|July 27, 2022
Zinc Modulation of Neuronal Calcium Sensor Proteins: Three Modes of Interaction with Different Structural OutcomesViktoriia E Baksheeva, Philipp O Tsvetkov, Arthur O Zalevsky, et al.
Consortium Psychiatricum|September 10, 2025
Comparative Analysis of Corpus Callosum Lipidome and Transcriptome in Schizophrenia and Healthy BrainMaria Osetrova, Olga Efimova, Marina Zavolskova, et al.
The Journal of Urology|March 25, 2026
UGN-102 for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: 24-Month Duration of Response Results From the Phase 3 ENVISION TrialSandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov, et al.
International Journal of Molecular Sciences|February 11, 2023
Myelin Basic Protein Fragmentation by Engineered Human Proteasomes with Different Catalytic Phenotypes Revealed Direct Peptide Ligands of MS-Associated and Protective HLA Class I MoleculesGeorge A Saratov, Vasiliy I Vladimirov, Alexey L Novoselov, et al.
Consortium Psychiatricum|September 10, 2025
Erratum to "Comparative Analysis of Corpus Callosum Lipidome and Transcriptome in Schizophrenia and Healthy Brain" (Consortium PSYCHIATRICUM, 2025, Volume 6, Issue 1, doi:10.17816/CP15491)Maria Osetrova, Olga Efimova, Marina Zavolskova, et al.
Pageof 99